Clinical Trial Update: Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a Technetium-99m labeled HYNIC-FAPI imaging agent to visualize fibroblast activation protein expression in several canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Technetium-99m HYNIC-FAPI imaging agent (Tc-99m HYNIC-FAPI)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Lung Cancer (Locally Advanced or Metastatic), Pancreas Cancer, Metastatic | Phase 1 | Status: ACTIVE_NOT_RECRUITING